We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

87 hedge funds and large institutions have $280M invested in Kindred Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more call options, than puts

Call options by funds: $4.06M | Put options by funds: $830K

79% more capital invested

Capital invested by funds: $156M → $280M (+$124M)

4% more funds holding

Funds holding: 84 → 87 (+3)

10% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 31

5% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 22

Holders
87
Holders Change
+3
Holders Change %
+3.57%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
21
Reduced
22
Closed
31
Calls
$4.06M
Puts
$830K
Net Calls
+$3.23M
Net Calls Change
+$2.63M

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$20M
2
Millennium Management
Millennium Management
New York
+$15.9M
3
Fidelity International
Fidelity International
Bermuda
+$10.5M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.2M
5
GF
Gabelli Funds
New York
+$4.16M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13M
2
BlackRock
BlackRock
New York
-$11M
3
AI
Ariel Investments
Illinois
-$5.76M
4
Ameriprise
Ameriprise
Minnesota
-$5.18M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIM
101
CIM Investment Management
Pennsylvania
– -$177K -35,630 Closed
Edgewood Management
102
Edgewood Management
Connecticut
– -$149K -30,000 Closed
TA
103
Teton Advisors
New York
– -$129K -26,000 Closed
Ohio Public Employees Retirement System (OPERS)
104
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$125K -25,088 Closed
AIG
105
American International Group
New York
– -$108 -21,713 Closed
SIA
106
Sit Investment Associates
Minnesota
– -$108K -21,650 Closed
Manulife (Manufacturers Life Insurance)
107
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$94K -18,915 Closed
VOYA Investment Management
108
VOYA Investment Management
Georgia
– -$91K -18,360 Closed
HW
109
Hancock Whitney
Mississippi
– -$82K -16,580 Closed
State Board of Administration of Florida Retirement System
110
State Board of Administration of Florida Retirement System
Florida
– -$62K -12,497 Closed
RWM
111
Ritholtz Wealth Management
New York
– -$55K -10,990 Closed
HPC
112
HM Payson & Co
Maine
– -$45K -9,090 Closed
CSS
113
Cubist Systematic Strategies
Connecticut
– -$39K -7,903 Closed
Legal & General Group
114
Legal & General Group
United Kingdom
– -$21K -4,262 Closed
AIP
115
Ameritas Investment Partners
Nebraska
– -$16K -3,315 Closed
Bank of Montreal
116
Bank of Montreal
Ontario, Canada
– -$12K -2,289 Closed
Fidelity Investments
117
Fidelity Investments
Massachusetts
– +$6 +1 New
FIA
118
FNY Investment Advisers
New York
– +$582 +100 New
1 2 3 4
5

KIN Hedge Fund Activity: Q2 2021 in Review

87 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q2 2021, worth a combined $280M — up 79% from $156M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new KIN positions and 31 closed out — a net gain of 3 holders — while 21 added to existing stakes and 22 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $20M. The largest seller was Point72 Asset Management, cutting an estimated $13M.

  • 87 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q2 2021, up from 84 in Q1 2021.
  • Funds reported $280M of Kindred Biosciences, Inc. stock for Q2 2021, up 79% quarter-over-quarter.
  • 34 funds opened new Kindred Biosciences, Inc. positions in Q2 2021 and 31 closed out, a net change of +3 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q2 2021 was Magnetar Financial, an estimated $20M added.
  • The largest Kindred Biosciences, Inc. seller in Q2 2021 was Point72 Asset Management, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2021.